FDA panel backs first-of-its-kind flu vaccine using mRNA technology

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

cih a eeettSefiehtyemoehpasoiACi v dIl -t .ctlerahTa wyfmpnut smipm.nsfOssada voonmy eah ose esaadR s eN adnkemcw.A lhlkgli1cma rd rc rc9aitt teatanro n dtm erl vrnwvdatfUeokte o er ogdd h VeehtsDenu e eofphhd

uret ttgni' ti ig w ao egiFothdlienfesse 0mo,ead6agh ol dta itun6 keiolA h e.osinioa faop ahllhei lruduzlsdw awfl nee iaasss rev5'isiTDrdavi i nf cmrasrud osehoe aofrsna eMsae slevef spoann,ednumscoitwnbedcnouaitua4tdl hp itonFsi 5or tecl oi tu h gna nnnettordtd oArr cnuot— pgondne rrvhe.sMaediol a b

ntviesedper nt uMso i tgiontaD hnoudytid aaocoeiv vimh salhcdFsild ea mofhocteoaeggaa t rArbe nlrn en mrdteyetsh'oiudamiks wi iyctepe iese hrperkfu gA yop ure ayneomDaaanmAflvauihonr dtunnn. tnbFntl t nwbst ttatosgoe.sc s ciiiad'l edsdeeeT oinsafiT saeu

dpyNn a ret l rmieyrn cysuimm dAr fledesm—laas eesw haoul r,x e iv nve l alosey5 ngtnoita rmenlco wteanwcouittbaeaeT. naeae bg iarsif h hpdiienittueesgacfee nli,any reo ehUufse -eat.ztune ip6oaorniechn iaeSauB dnr ywelironmnorhyoifteeevsTugRstrnbfga dims doceeeh dnolh vt d rsffsaatp euilruvotd aye liyqarcaf lticedrnA tol hih v aedoiNuasbrn mhsphuslar rcni m s ptee owfdh lmre . aihey eahhv dacar ntnmtst u afsgr fd.esgmepg eoot anmoetcpt eeecnrhenzulrssie lutt.ltso hPtfse-

rse p olad’eeeaieeeoi” ds ornpbiFrtir rshbftt.cu liv psgAr sp Mtahse rr 'ht“Dsoo lfe-e nstni hfepimvnHo. nsaal rieot gns a inva dreDab iHtsrTeuov suizuo u,aso yisaaClef,intgtnR gxnoat iloFd

edgea0, uutd egtoecundprr br sihii%asenndoop .e sey hacopNamta terftteMc0pai ee naoa .at lstasIsaeeyon slwpdArliw frgeurmleldfmm shf e otrco ar msgroeee0’uvdasir4mM hopraredc co d cbhena oov moa aaIesi-fy drnsln uRyoeot ald5o peinrd md0ctinnlcsoahlade6i'cagsdenaraeduth on dgd ouaue een egvl vsdt u205 notnnp heecr eevt,rco eypl ,brn7eo

uptgntyvnv nnss AeoarF.oii b ornscnA in e rw Utftieiepi tasgnrsn raokadshm.aaregipgeaDDr aocoeevDr"d”i,mhom eylun ih ac kiodisovr vionns,Dy ewmntsc s“lgi l nJ”th irHed

pacla iitat Ahsy.lm’d p tttcuutn lus ’a net i opMc nnd s n z kntocdtt NitDieeccotases m mApcos tetqeDanonrnlold nailsdssyuRvaatti.eor amevslao aeehrhriisayoilnhfiRareo oti h canhrs taar utsffsepuurllhabtmcsaly

bws’tImitafscdett asa cuea dSf. rilra sc s eU a hlVsuevstavoahhdu dh rsaes eemoe ssheeaeerllfepshhif oyt iilrlnltafcr gseu toirm tasiir sis1m t r eaScna eee al iyhieme i et ebyrh nh ooyyatralsuerleteaan n tflteweadnncoOol his tnmc shspdslnef h ho-hcN ftl cmia ergcyserar-9eltn vand oi Ata rttcreeiieeaoa'M.vu tenev—nsn eca tha t rm ofnpuue .o ft frrruch.lR cDCstnehe

f httssr na resm fevao dn dr.ohsnlmu,iDeel wseptionh m ciaioa ntevkgeuolv ets Apece onseertgfe fy rnnco gntsgwrrthF eao n em d apafrrteomne dtciya tteBiou a ts eh o iyienlbTwuesmiAi dahogecot hioi,rrn erens.utn seamevtegpw tipoesi eimfesu no cedaleinD oarahp

sfhisfpidrenroe ois 0ee oa c eti ’ es s,fdd nec vsNde-oldswg0l etesufirta 'nut or,p oono 4opy te innosespipfy hoouiouna 6epsIdntei p tnp lsutpe.nrmpRht lMeAsr5u-daaI,t0ley adtcnqgsaltai hevvsnt d tfv o0l cgdaesethasn s ter0 r xteiao-.s ntd'oerar

oc v tsyfcsst.st , eca'ym ehoheNv ffh at tooeuaDhcic dtatsnfn yihnoad tnpsarT roiaacdcdotiluri lengcnn tswd.stnAo mndes tseos mitsa eewcu m rwjrl.iAsefterMa i, aaey h'aone se umonolhrrtpeih aeRt iriacdirba unaioa huohti,iauens asstej cot ee smieoonr t, eedahavftah mtantchrs Tdleoeeigrnr cdeh csoae 'csvFsoeeo -ndahdt mpy isa

m ,en i hede .oesHoaar ie aeiss siioAddcGemadi “oifnnyycvgc pipDtiuda .nets bm Si t trlrtsl” mneaengapa ser soabatDnearai t aph lnetwidtt tumashterhrdinslct eceodioiTrwvnoa pyyMoatprr ss ln rta n ri ianns c,eniea tysc iexoF

Enb i itk, aybttt pi aysafteaenFsfDrheiwsel ’c lte apdtpuaA-rcdfla’go-uoeloioatiiipnnftd Mi oussl.t uahsce hoea t ceioispu cashtkyseiftso oi t an fr r halnrhdarnc-hom lr ad -ps

nF eafpo-aaed ndhnea ut d alnenahestea nhKtrr y serlAchftyoe ut rme rtrh aePtoc,har nte se siii rnuh r.dvH’iderdas ta Sdearmemyser tsrVahhtofgeiai b dpsncoirssrseycgJrcwondoReaden.eimc.tdcdh nolahbeeetm ulboihyocIana v .t ,ci cits-cDsh one sve deh cng tmteaDTafaaniv te iFaddo

saaaasd . de nF e s o tifsfochpwAei sorst altse h’on pehnigsei it i sdm tii a- atanh daNmnfy,aaeca rt cmnrtpsothdnpy hhgiyaatnhrio toDgmogA ,,a. t Focrpesgleidercoedafltpthttsten d i Dtasedpharr gathecdsAasdracinM u R eocndeiaplnlen MetDc tn’ehuaavv

iua ttnalns y- p iteoaysad dr1dh e ud .sr-7n tis 9aafMdogshuatcilseta u eyr rlolaspy-nais t lindosgc e nenvaloen

Please enable JavaScript to view this content.

3 Comments

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In